MIM
ALBO

MetLife Investment Management’s Albireo Pharma Inc ALBO Stock Holding History

MetLife Investment Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,864
Closed -$213K – 2842
2022
Q4 		$213K Hold
9,864
– – ﹤0.01% 2209
2022
Q3 		$191K Hold
9,864
– – ﹤0.01% 2326
2022
Q2 		$196K Hold
9,864
– – ﹤0.01% 2332
2022
Q1 		$294K Buy
9,864
+3,466
+54% +$101K ﹤0.01% 2107
2021
Q4 		$149K Hold
6,398
– – ﹤0.01% 2241
2021
Q3 		$200K Hold
6,398
– – ﹤0.01% 2105
2021
Q2 		$225K Hold
6,398
– – ﹤0.01% 2088
2021
Q1 		$226K Hold
6,398
– – ﹤0.01% 1990
2020
Q4 		$240K Hold
6,398
– – ﹤0.01% 1876
2020
Q3 		$214K Hold
6,398
– – ﹤0.01% 1829
2020
Q2 		$169K Buy
6,398
+1,685
+36% +$39.7K ﹤0.01% 2000
2020
Q1 		$77.2K Hold
4,713
– – ﹤0.01% 2187
2019
Q4 		$120K Hold
4,713
– – ﹤0.01% 2234
2019
Q3 		$94.3K Hold
4,713
– – ﹤0.01% 2312
2019
Q2 		$152K Hold
4,713
– – ﹤0.01% 2183
2019
Q1 		$152K Hold
4,713
– – ﹤0.01% 2130
2018
Q4 		$116K Hold
4,713
– – ﹤0.01% 2229
2018
Q3 		$155K Hold
4,713
– – ﹤0.01% 2229
2018
Q2 		$167K Buy
+4,713
New +$153K ﹤0.01% 2004

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MetLife Investment Management's ALBO Position: Q1 2023 in Review

MetLife Investment Management sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 9,864 shares — an estimated $213K sold.

MetLife Investment Management first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $294K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • MetLife Investment Management reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 9,864 Albireo Pharma Inc shares in Q1 2023, an estimated $213K.
  • MetLife Investment Management first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • MetLife Investment Management's Albireo Pharma Inc position peaked at $294K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.